冠脉CTA血管周围脂肪衰减指数与HCM心力衰竭相关
本研究回顾性纳入75例肥厚型心肌病患者及75例年龄性别匹配的无结构性心脏病对照,基于冠脉CTA测量LAD、LCX、RCA近段血管周围FAI,并进行心脏MR评估。结果显示HCM组三支血管FAI均显著升高,LAD-FAI与心衰独立相关,提示其可能作为HCM危险分层的影像标志物。
要点
- HCM患者LAD、LCX、RCA近段血管周围FAI均显著高于对照组
- LAD-FAI与左室质量指数及整体应变参数存在显著相关
- 多因素回归中LAD-FAI与心衰独立相关,阅片时可关注LAD周围脂肪密度
核心结论
- HCM患者冠脉炎症显著增高,LAD-FAI与左室肥厚及功能障碍相关,调整CMR参数后仍与心衰独立相关
研究设计与样本
- 回顾性研究,纳入75例HCM患者及75例年龄性别匹配的无结构性心脏病对照
- 所有患者接受冠脉CTA测量近段RCA、LAD、LCX血管周围FAI,并完成心脏磁共振评估左室形态、功能及应变参数
关键影像表现/征象
- HCM组三支血管FAI均显著高于对照组:LAD-FAI -75.49±9.04对-83.25±8.97 HU
- LCX-FAI -71.96±9.62对-79.48±8.51 HU,RCA-FAI -77.57±10.25对-83.20±8.98 HU,均p<0.001
- LAD-FAI与左室质量指数及整体应变参数等左室不良重构指标存在显著相关
诊断标准与关键数值
- 多因素logistic回归显示LAD-FAI与心衰独立相关,OR为1.40,95%CI 1.12-1.99,p=0.018
临床应用与阅片要点
- 在HCM患者冠脉CTA报告中除管腔狭窄外,可关注LAD近段血管周围脂肪衰减指数的升高
- LAD-FAI升高提示冠脉区域炎症,可能伴左室不良重构及心衰风险增加,提示临床进一步CMR评估
局限性
- 回顾性研究设计
- 原文提示需在更大规模、前瞻性、多中心队列中进一步验证
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This study aimed to evaluate coronary inflammation using the perivascular fat attenuation index (FAI) derived from coronary computed tomography angiography (CCTA) in patients with hypertrophic cardiomyopathy (HCM) and to investigate its association with heart failure (HF).
METHODS: This retrospective study included 75 patients with HCM and 75 age- and sex-matched controls without structural heart disease. Perivascular FAI was measured around the proximal right coronary artery (RCA), left anterior descending artery (LAD), and left circumflex artery (LCX). All patients underwent cardiac magnetic resonance imaging for comprehensive assessment of left ventricular (LV) morphology, function, and strain parameters.
RESULTS: FAI values were significantly elevated in HCM patients compared to controls across all three vessels: LAD-FAI (-75.49 ± 9.04 vs. -83.25 ± 8.97 HU), LCX-FAI (-71.96 ± 9.62 vs. -79.48 ± 8.51 HU), and RCA-FAI (-77.57 ± 10.25 vs. -83.20 ± 8.98 HU); all p < 0.001. LAD-FAI demonstrated modest but significant correlations with markers of adverse LV remodeling, including LV mass index and global strain parameters. On multivariable logistic regression analysis, LAD-FAI was independently associated with HF (OR: 1.40; 95% CI: 1.12-1.99; p = 0.018).
CONCLUSION: Coronary inflammation, quantified by perivascular FAI on CCTA, is significantly heightened in patients with HCM and is correlated with LV hypertrophy and dysfunction. Notably, increased LAD-FAI is independently associated with heart failure after adjustment for the included CMR parameters, suggesting its potential utility as a non-invasive imaging biomarker for risk stratification in HCM, pending external validation.
ADVANCES IN KNOWLEDGE: This study provides initial evidence that perivascular FAI, a non-invasive imaging marker of coronary inflammation, is significantly elevated in patients with HCM and correlates with adverse left ventricular remodeling, impaired myocardial strain, and elevated NT-proBNP levels. Notably, increased LAD-FAI was independently associated with heart failure, suggesting a mechanistic link between regional coronary inflammation and disease severity in HCM. These findings highlight the potential utility of perivascular FAI as an imaging biomarker for heart failure risk stratification in HCM, warranting further validation in larger, prospective multicenter cohorts.
引用
- Peng, Feng, Yuan, et al. Coronary CT angiography-derived perivascular fat attenuation index as a potential marker for heart failure in hypertrophic cardiomyopathy. Br J Radiol. 2026. PMID: 42627363. doi:10.1093/bjr/tqag195
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。